Quipt Home Medical Corp.

    Quipt Home Medical Corp.

    NNASDAQ:QIPT
    3.65
    USD
    0.00
    (0.00%)
    2013 Y
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    2025 Y
    TTM
    Revenue per Share
    1.12
    2.94
    4.65
    4.13
    3.27
    2.89
    2.95
    3.2
    3.36
    4.05
    5.32
    5.79
    5.67
    6.1
    Basic EPS, GAAP
    -0.72
    -0.22
    -1.57
    -3.23
    -1.02
    0.77
    -0.27
    -0.2
    -0.2
    0.14
    -0.07
    -0.16
    -0.25
    -0.25
    Free Cash Flow per Basic Share
    -0.34
    -0.48
    -0.69
    -0.82
    -0.39
    0.54
    0.4
    0.61
    0.42
    0.5
    0.76
    0.59
    0.59
    0.61
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    0.1
    1.33
    9.67
    3.65
    2.65
    -0.5
    -0.15
    0.52
    1.21
    1.54
    -4.12
    -4.01
    -4.19
    -4.2
    Tangible Book Value per Share
    0.04
    0.73
    4.5
    2.07
    3.57
    0.58
    0.45
    0.83
    1.03
    0.65
    -0.4
    -0.27
    -0.62
    -0.56
    Basic Weighted Avg Shares
    3
    6
    11
    18
    19
    19
    21
    23
    30
    35
    40
    43
    43
    43
    Sales/Revenue/Turnover
    4
    19
    53
    73
    62
    55
    61
    73
    102
    140
    212
    246
    245
    265
    Operating Margin (%)
    7.47
    -0.48
    -12.7
    -30.28
    -16.88
    -9.73
    -1.55
    -0.87
    -1.29
    1.2
    2.74
    1.44
    -0.79
    -0.43
    Depreciation Expense
    - -
    2
    9
    11
    12
    12
    11
    15
    18
    23
    41
    51
    52
    54
    Net Income, GAAP
    -2
    -1
    -18
    -57
    -19
    15
    -6
    -5
    -6
    5
    -3
    -7
    -11
    -11
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    -64.05
    -7.38
    -33.68
    -78.3
    -31.11
    26.59
    -9.12
    -6.29
    -6.03
    3.46
    -1.32
    -2.75
    -4.36
    -4.03
    Working Capital
    4
    2
    42
    16
    58
    4
    7
    21
    24
    - -
    5
    12
    4
    3
    LT Debt
    - -
    4
    5
    6
    7
    9
    13
    17
    17
    11
    75
    78
    96
    91
    Total Equity
    1
    13
    131
    91
    72
    15
    13
    28
    59
    80
    111
    107
    112
    113
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    -549.47
    -31.23
    -30.06
    -65.22
    -33.36
    - -
    - -
    - -
    -25.37
    10.73
    -4.07
    - -
    - -
    - -

    Capital Structure

    USD

    •

    in mil. unless spec.
    Jun'25
    Sep'25
    Dec'26
    ST Debt
    20
    23
    23
    LT Borrowings
    62
    82
    79
    LT Finance Leases
    11
    13
    13
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    43
    43
    44
    Market Capitalization
    105
    157
    210

    Working Capital

    USD

    •

    in mil. unless spec.
    Jun'25
    Sep'25
    Dec'26
    Total Current Assets
    69
    78
    78
    Cash, Cash Equivalents & STI
    11
    13
    11
    Accounts Receivable, Net
    27
    35
    35
    Inventories
    24
    26
    27
    Total Current Liabilities
    60
    75
    75
    Payables & Accruals
    34
    41
    41
    ST Debt
    20
    23
    23
    Deferred Revenue
    4
    5
    4

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    15.7%
    36.81%
    4.58%
    Free Cash Flow
    -6.8%
    17.19%
    1.08%
    Net Income, GAAP
    -27.97%
    -19.94%
    58.23%
    Sales/Revenue/Turnover
    18.55%
    28.97%
    -0.23%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    63
    61
    61
    53
    246
    2025
    61
    57
    58
    68
    245
    2026
    81
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    -0.04
    -0.02
    -0.04
    - -
    -0.16
    2025
    -0.03
    -0.07
    -0.07
    - -
    -0.25
    2026
    -0.02
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    2026
    - -
    - -
    - -
    - -
    - -

    Company Description

    Company Profile APIChatGPT
    Address
    Similar Companies
    Business

    Company News

    Company News APIChatGPT

    • defenseworld.net

      Head to Head Comparison: QuidelOrtho (NASDAQ:QDEL) vs. Quipt Home Medical (NASDAQ:QIPT)

    • globenewswire.com

      Quipt Home Medical Receives Final Order Approving Arrangement

    • globenewswire.com

      Quipt Home Medical Announces Voting Results From Special Meeting of Shareholders

    • globenewswire.com

      Quipt Home Medical Corp. Announces Filing and Mailing of Proxy Statement and Information Circular and Receipt of Interim Order in Connection With Plan of Arrangement

    • prnewswire.com

      Shareholder Alert: The Ademi Firm investigates whether Quipt Home Medical Corp. is obtaining a Fair Price for its Public Shareholders

    • defenseworld.net

      Quipt Home Medical Target of Unusually Large Options Trading (NASDAQ:QIPT)

    • prnewswire.com

      $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Quipt Home Medical Corp. (NASDAQ: QIPT)

    • businesswire.com

      QIPT Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Quipt Home Medical Corp. is Fair to Shareholders

    • businesswire.com

      Concerned Shareholder Bradley L. Radoff Urges Quipt Home Medical's Board of Directors to Pursue a Value-Maximizing Sale

    • businesswire.com

      Lakeview Urges Quipt's Board to Initiate a Legitimate Review of All Strategic Options Including a Sale, Inclusive of a Credible Bidder's $3.10 All-Cash Offer

    • zacks.com

      All You Need to Know About Quipt Home Medical (QIPT) Rating Upgrade to Buy

    • globenewswire.com

      Quipt Home Medical Completes Strategic Acquisition of Hart Medical Adding $60 Million in Revenue

    • https://thefly.com

      Quipt Home Medical price target raised to $2.30 from $1.70 at Canaccord

    • seekingalpha.com

      Quipt Home Medical Corp. (QIPT) Q3 2025 Earnings Call Transcript

    • globenewswire.com

      Quipt Home Medical Partners With Three Major Health Systems to Form Strategic Joint Venture

    • globenewswire.com

      Quipt Home Medical Reports Improved Fiscal Third Quarter 2025 Results

    • globenewswire.com

      Quipt Home Medical Corp. to Announce Fiscal Third Quarter 2025 Financial Results on August 11, 2025

    • prnewswire.com

      INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Quipt Home Medical Corp. - QIPT

    • prnewswire.com

      INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Quipt Home Medical Corp. - QIPT

    • prnewswire.com

      INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Quipt Home Medical Corp. - QIPT